These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35765176)

  • 1. Rituximab pediatric drug development: Pharmacokinetic and pharmacodynamic modeling to inform regulatory approval for rituximab treatment in patients with granulomatosis with polyangiitis or microscopic polyangiitis.
    Jamois C; Gibiansky L; Chavanne C; Cheu M; Lehane PB; Pordeli P; Melega S; Gaudreault J
    Clin Transl Sci; 2022 Sep; 15(9):2172-2183. PubMed ID: 35765176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase IIa Global Study Evaluating Rituximab for the Treatment of Pediatric Patients With Granulomatosis With Polyangiitis or Microscopic Polyangiitis.
    Brogan P; Yeung RSM; Cleary G; Rangaraj S; Kasapcopur O; Hersh AO; Li S; Paripovic D; Schikler K; Zeft A; Bracaglia C; Eleftheriou D; Pordeli P; Melega S; Jamois C; Gaudreault J; Michalska M; Brunetta P; Cooper JC; Lehane PB;
    Arthritis Rheumatol; 2022 Jan; 74(1):124-133. PubMed ID: 34164952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Safety of Rituximab in Granulomatosis With Polyangiitis and in Microscopic Polyangiitis.
    Merkel PA; Niles JL; Mertz LE; Lehane PB; Pordeli P; Erblang F
    Arthritis Care Res (Hoboken); 2021 Sep; 73(9):1372-1378. PubMed ID: 32475029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab induction and reinduction in granulomatosis with polyangiitis and microscopic polyangiitis: A retrospective multicenter study in Taiwan.
    Hsieh TY; Chen MH; Wu CC; Hong WJ; Lu CH; Lu CC; Lu LY; Hsieh SC; Tsai CY; Wu CS;
    Int J Rheum Dis; 2023 Dec; 26(12):2441-2449. PubMed ID: 37784228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti B-cell-antibody treatment for maintenance of remission in granulomatosis with polyangiitis and microscopic polyangiitis].
    de Groot K; Aries PM; Haubitz M; Hellmich B; Lamprecht P; Thiel J
    Dtsch Med Wochenschr; 2020 Jan; 145(1):40-46. PubMed ID: 31914468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab (MABTHERA) and severe polyangiitis. An option for patients informed of the uncertainties.
    Prescrire Int; 2015 Jun; 24(161):145-8. PubMed ID: 26436161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab Biosimilar Prevents Poor Outcomes of Microscopic Polyangiitis and Granulomatosis with Polyangiitis as Effectively as Rituximab Originator.
    Kwon HC; Kim MK; Song JJ; Park YB; Lee SW
    Yonsei Med J; 2020 Aug; 61(8):712-719. PubMed ID: 32734735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-cytokine targeted therapies for ANCA-associated vasculitis.
    Bala MM; Malecka-Massalska TJ; Koperny M; Zajac JF; Jarczewski JD; Szczeklik W
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD008333. PubMed ID: 32990324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing Presenting Clinical Features in 48 Children With Microscopic Polyangiitis to 183 Children Who Have Granulomatosis With Polyangiitis (Wegener's): An ARChiVe Cohort Study.
    Cabral DA; Canter DL; Muscal E; Nanda K; Wahezi DM; Spalding SJ; Twilt M; Benseler SM; Campillo S; Charuvanij S; Dancey P; Eberhard BA; Elder ME; Hersh A; Higgins GC; Huber AM; Khubchandani R; Kim S; Klein-Gitelman M; Kostik MM; Lawson EF; Lee T; Lubieniecka JM; McCurdy D; Moorthy LN; Morishita KA; Nielsen SM; O'Neil KM; Reiff A; Ristic G; Robinson AB; Sarmiento A; Shenoi S; Toth MB; Van Mater HA; Wagner-Weiner L; Weiss JE; White AJ; Yeung RS;
    Arthritis Rheumatol; 2016 Oct; 68(10):2514-26. PubMed ID: 27111558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive multifocal leukoencephalopathy in rituximab-treated rheumatic diseases: a rare event.
    Berger JR; Malik V; Lacey S; Brunetta P; Lehane PB
    J Neurovirol; 2018 Jun; 24(3):323-331. PubMed ID: 29508305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular targeted therapies for microscopic polyangiitis and granulomatosis with polyangiitis.
    Harigai M; Tsutsumino M; Takada H; Nagasaka K
    Korean J Intern Med; 2019 May; 34(3):492-503. PubMed ID: 30613065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Update on treatment of ANCA-associated vasculitis: Granulomatosis with polyangiitis and Microscopic Polyangiitis].
    Holle JU; Hellmich B; Moosig F
    Z Rheumatol; 2022 May; 81(4):280-285. PubMed ID: 35061059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on maintenance therapy for granulomatosis with polyangiitis and microscopic polyangiitis.
    Singer O; McCune WJ
    Curr Opin Rheumatol; 2017 May; 29(3):248-253. PubMed ID: 28306595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Childhood-onset granulomatosis with polyangiitis and microscopic polyangiitis: systematic review and meta-analysis.
    Iudici M; Quartier P; Terrier B; Mouthon L; Guillevin L; Puéchal X
    Orphanet J Rare Dis; 2016 Oct; 11(1):141. PubMed ID: 27770813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulomatous Vasculitis.
    Sharma A; Dogra S; Sharma K
    Dermatol Clin; 2015 Jul; 33(3):475-87. PubMed ID: 26143427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting factors for relapse in patients with granulomatosis with polyangiitis: results from a long-term cohort.
    Mehrabi Nejad MM; Jazayeri SB; Ayoobi Yazdi N; Afshar A; Alesaeidi S
    Clin Rheumatol; 2022 Aug; 41(8):2457-2465. PubMed ID: 35397719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Serious Infection in Pediatric Patients with Low Immunoglobulin Levels Receiving Rituximab for Granulomatosis with Polyangiitis or Microscopic Polyangiitis.
    Melega S; Brogan P; Cleary G; Hersh AO; Kasapcopur O; Rangaraj S; Yeung RSM; Zeft A; Cooper J; Pordeli P; Kirchner P; Lehane PB
    Rheumatol Ther; 2022 Apr; 9(2):721-734. PubMed ID: 35279811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of eosinophilic granulomatosis with polyangiitis during the clinical course of microscopic polyangiitis: A case report.
    Ide H; Shimizu T; Koike Y; Abe K; Shigematsu K; Nishihata S; Kojima K; Ichinose K; Kawakami A
    Medicine (Baltimore); 2022 Nov; 101(44):e31401. PubMed ID: 36343053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different responses to treatment across classified diseases and severities in Japanese patients with microscopic polyangiitis and granulomatosis with polyangiitis: a nationwide prospective inception cohort study.
    Sada KE; Yamamura M; Harigai M; Fujii T; Takasaki Y; Amano K; Fujimoto S; Muso E; Murakawa Y; Arimura Y; Makino H;
    Arthritis Res Ther; 2015 Nov; 17():305. PubMed ID: 26525413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pediatric ANCA-associated vasculitis, a case series].
    Javiera Cid B; Feuerhake T; Méndez GP; Talesnik E; Borzutzky A
    Andes Pediatr; 2021 Dec; 92(6):904-910. PubMed ID: 35506802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.